Pfizer R&D closure tests local economy

Pfizer, the US-based pharmaceuticals giant, announced the closure of its 50-year old, 2,400-person research and development facility in the UK town of Sandwich in February. Andrew Jack, pharmaceuticals correspondent, travels to the Kent community to find out how the news is affecting residents, employees and local business.